November 11, 2026 12:52 PM
Cheaper cancer medicines: What the new 30% trade margin cap means for patients
Cancer treatment can place a substantial financial burden on patients and their families, particularly when the cost of medicines rises significantly between the manufacturer and the retail counter. To address this concern, the Centre has introduced a 30% cap on trade margins for 137 non-scheduled anti-cancer medicines, aiming to reduce the prices patients pay for these drugs. The National Pharmaceutical Pricing Authority (NPPA), through an order issued on October 17, 2026, brought the medicine...


